Last checked at 17 Dec 2009 14:38
| For immediate release | 17 December 2009 |
Futura Medical plc
("Futura" or "the Company")
Director's Dealings
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that it has received notification from James Barder, the Chief Executive of the Company, that he and his wife have today gifted in aggregate 100,000 ordinary shares in the Company to a shareholding account jointly held by their children.
For the purposes of the AIM Rules for Companies, Mr Barder will continue to treat such shares as consolidated within his and his wife's holding and as such his aggregate beneficial and non-beneficial holdings will remain unchanged at 720,212 ordinary shares.
For any further information please contact:
| Futura Medical plc | |
| James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
| mail to: james.barder@futuramedical.com | www.futuramedical.com |
| Nomura Code Securities Limited | |
| Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
| For media enquiries please contact: | |
| Buchanan Communications | |
| Mark Court / Stasa Filiplic / Jennie Spivey | Tel: +44 (0) 20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com